M I Whitehead

No ORCID on file · 11 papers in corpus
review 1999
British journal of obstetrics and gynaecology ·doi:10.1111/j.1471-0528.1999.tb08358.x
rct 1997
Maturitas ·doi:10.1016/s0378-5122(97)00058-3

OBJECTIVE: To study the effects of oral trimegestone on endometrial histology and vaginal bleeding when given in combination with oral 17-beta-oestradiol. METHODS: This was a prospective, randomised, double-blind, parallel groups, pilot co…

review 1997
BMJ (Clinical research ed.) ·doi:10.1136/bmj.315.7099.37
other 1993
BMJ (Clinical research ed.) ·doi:10.1136/bmj.306.6884.1025

OBJECTIVE: To assess the value of transvaginal ultrasonography with colour blood flow imaging in detecting early ovarian cancer in women with a family history of the disease. DESIGN: Study of self referred symptomless women with a close re…

review 1990
Drug safety ·doi:10.2165/00002018-199005050-00004

Estrogen therapy is extremely effective in relieving menopausal symptoms such as hot flushes, night sweats, urogenital atrophy and certain psychological symptoms. The short term side effects from this therapy are usually mild and self-limit…

other 1990
BMJ (Clinical research ed.) ·doi:10.1136/bmj.300.6722.436

OBJECTIVE: To provide information on endometrial stimulation after discontinuation of treatment with oestradiol implants. DESIGN: Long term follow up of withdrawal bleeding patterns in women taking progestogens cyclically every month after…

other 1989
British journal of obstetrics and gynaecology ·doi:10.1111/j.1471-0528.1989.tb03315.x

Although progestogens protect the endometrium against excessive oestrogen-induced stimulation, they can cause adverse symptomatic and psychological effects and may have undesirable metabolic consequences. Thus, the minimum progestogen dose …

other 1989
BMJ (Clinical research ed.) ·doi:10.1136/bmj.299.6712.1363

OBJECTIVE: To assess the value of ultrasonography in a screening procedure for early ovarian cancer. DESIGN: Prospective study of at least 5000 self referred women without symptoms of ovarian cancer. Each woman was scheduled to undergo thr…

nonrandomized-trial 1986
British journal of obstetrics and gynaecology ·doi:10.1111/j.1471-0528.1986.tb07814.x

Postmenopausal women receiving conjugated oestrogens 1.25 mg daily continuously were also given dydrogesterone either 5, 10 or 20 mg daily for the first 12 days of each calendar month. Endometrial tissue obtained on the sixth day of combine…

case-report 1983
British medical journal (Clinical research ed.) ·doi:10.1136/bmj.287.6397.946
nonrandomized-trial 1980
British medical journal ·doi:10.1136/bmj.280.6217.825

The absorption, metabolism, and clearance of progesterone from the peripheral circulation were investigated in five postmenopausal women after oral administration of 100 mg daily for five consecutive days. Maximal plasma concentrations of p…